ScopusElsevier Scopus
Status
Active
Coverage
2012–2024
Source type
Journal
Open access
No
CiteScore
3.2
Best quartile
Q2 · 52nd pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 91 / 191 | 52nd | Q2 |
| Drug Discovery | 109 / 161 | 32nd | Q3 |
Pharmaceutical Patent Analyst
ISSN 2046-8954 · 2046-8962
Publisher: Taylor and Francis Ltd.
Scopus · Q2
Is Pharmaceutical Patent Analyst indexed in Scopus? Yes — actively indexed in Scopus, coverage 2012–2024, best quartile Q2, CiteScore 3.2.
Is Pharmaceutical Patent Analyst in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Pharmaceutical Patent Analyst open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
3.2
CiteScore 2025
Scopus
Q2
Best quartile
52nd percentile
1
Indexed in
major index
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.